Latest Science New hepatitis C vaccine overcomes previous barriers A prophylactic hepatitis C virus (HCV) vaccine produces a long-lasting, sustained T-cell response that is characteristic of the T-cell response associated with a controlled HCV infection. Researchers have evaluated the... 7 November, 20143 min read